"Your health and safety are always our top priority. To help you protect yourself and your loved ones, we’ve gathered the most important information and guidance on the coronavirus and COVID-19. Go to our website. You have many ways to get care without leaving the comfort of your home - including an e-visit, phone, video appointments, and email. This allows you to still get great care while helping to address the community spread of COVID-19. If you’re concerned about your specific health condition, call 1-833-KP4CARE (1-833-574-2273) (TTY 711) to talk to a licensed care provider 24/7. For answers to your general questions about COVID-19, call our new information line for Kaiser Permanente members at 1-877-813-7297."

During the past decade, Kaiser Permanente Downey Medical Center conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 87 clinical trials were completed, i.e. on average, 135.9% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 33 clinical trials were completed. i.e. 183.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente Downey Medical Center" #1 sponsor was "Children's Oncology Group" with 137 trials, followed by "National Cancer Institute (NCI)" with 55 trials sponsored, "Kaiser Permanente" with 2 trials sponsored, "NICHD Pelvic Floor Disorders Network" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Downey Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 137 trials as a collaborator, "Children's Oncology Group" with 8 trials as a collaborator, "Kaiser Permanente" with 3 trials as a collaborator, "Duke University" with 2 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Downey Medical Center" are "Recurrent Neuroblastoma" (22 trials), "Recurrent Osteosarcoma" (18 trials), "Refractory Neuroblastoma" (15 trials), "Refractory Non-Hodgkin Lymphoma" (14 trials) and "Sarcoma" (14 trials). Many other conditions were trialed in "Kaiser Permanente Downey Medical Center" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente Downey Medical Center" are "Drug" (158 trials), "Other" (99 trials), "Biological" (71 trials), "Procedure" (67 trials) and "Radiation" (56 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (64 trials), "Cyclophosphamide" (37 trials), "Vincristine Sulfate" (32 trials), "Etoposide" (30 trials) and "cyclophosphamide" (28 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente Downey Medical Center" are 196 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente Downey Medical Center". undefined are not yet recruiting, 31 are recruiting, 63 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 104 completed trials in Kaiser Permanente Downey Medical Center, 2 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente Downey Medical Center, 10 "Phase 1" clinical trials were conducted, 87 "Phase 2" clinical trials and 78 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".